Search Results 321-330 of 17083 for immunothérapie
Research. Mayo Clinic doctors and scientists in the David F. and Margaret T. Grohne Cancer Immunology and Immunotherapeutics Research Program are pursuing ...
The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...
The purpose of this study is to find out more about certain markers of immune suppression in people with kidney tumors (whether the tumors are benign or ...
Find out more about the symptoms, diagnosis and treatment of this cancer of the lymphatic system.
About this study. The purpose of this study is to demonstrate 1) feasibility of digital biomarker assessment using wearable in children with solid tumors ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!